Mary Tsikitis

Dr. Mary Tsikitis


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Current Opinion in Cell Biology
Verified
Journal Article
Closed access
YCYassemi Capetanaki
Yassemi Capetanaki
SPStamatis Papathanasiou
Stamatis Papathanasiou
ADAntigoni Diokmetzidou
Antigoni Diokmetzidou
GVGiannis Vatsellas
Giannis Vatsellas
MTMary Tsikitis
Mary Tsikitis

29 March 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
DKDimitra Kerdidani
Dimitra Kerdidani
PCPanagiotis Chouvardas
Panagiotis Chouvardas
AAAres Rocanin Arjo
Ares Rocanin Arjo
IGIoanna Giopanou
Ioanna Giopanou
GNGiannoula Ntaliarda
Giannoula Ntaliarda
MTMaria Tsoumakidou
Maria Tsoumakidou
Lung adenocarcinoma (LUAD)-derived Wnts increase cancer cell proliferative/stemness potential, but whether they impact the immune microenvironment is unknown. Here we show that LUAD cells use paracrine Wnt1 signaling to induce immune resistance. In TCGA, Wnt1 correlates strongly with tolerogenic genes. In another LUAD cohort, Wnt1 inversely associates with T cell abundance. Altering Wnt1 expression profoundly affects growth of murine lung adenocarcinomas and this is dependent on conventional dendritic cells (cDCs) and T cells. Mechanistically, Wnt1 leads to transcriptional silencing of CC/CXC chemokines in cDCs, T cell exclusion and cross-tolerance. Wnt-target genes are up-regulated in human intratumoral cDCs and decrease upon silencing Wnt1, accompanied by enhanced T cell cytotoxicity. siWnt1-nanoparticles given as single therapy or part of combinatorial immunotherapies act at both arms of the cancer-immune ecosystem to halt tumor growth. Collectively, our studies show that Wnt1 induces immunologically cold tumors through cDCs and highlight its immunotherapeutic targeting.

16 October 2025 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
MTMary Tsikitis
Mary Tsikitis
ADAntigoni Diokmetzidou
Antigoni Diokmetzidou
PLPanagiotis Liakopoulos
Panagiotis Liakopoulos
MKMaria Karipidou
Maria Karipidou
IKIoannis Kokkinopoulos
Ioannis Kokkinopoulos
YCYassemi Capetanaki
Yassemi Capetanaki
The cardiac cytoskeleton is essential for the proper intracellular and intercellular integration of cardiomyocyte structure, maintenance and function, failure of which leads to cell death and heart disease. In particular, the desmin intermediate filament cytoskeleton, due to its early expression and subcellular distribution, enables the formation of a continuous network that connects the extracellular space with the nuclear matrix, thus allowing us to hypothesize potential key roles in mechanotransduction to the nucleus, and consequently, in cardiac lineage determination, differentiation and development. Here, we investigated the role of desmin in cardiac differentiation and homeostasis across embryogenesis, postnatal life, and adulthood, as well as under various stimuli. Desmin was found to be highly expressed in cardiac progenitor cells during embryogenesis, and its absence significantly impacts the size of this population. Using direct cellular reprogramming of fibroblasts to induced cardiomyocytes, we demonstrated that ectopic desmin expression directly influences cardiomyogenesis, potentially linked, among others, to transcriptional regulation of the Notch1 signaling. Conversely, desmin deficiency leads to substantial perturbations in cardiac maturation by diminishing the expression and proper localization of cardiac-specific proteins, impairing calcium homeostasis and delaying myofibril formation. RNA and ChIP sequencing, coupled with Hi-C analysis, revealed that desmin depletion causes chromatin architectural disruptions, altering genome organization and gene expression of cardiac-specific modulators, contributing to pathophysiological phenotype.